Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             197 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 128 A cellular GPI-specific phospholipase D regulates the biological function of the urokinase receptor Wilhelm, O.
 1997
 S3 p. 36-
1 p.
 artikel
2 127 Activation of GPI-specific phospholipase D by acylation Escott, G.M.
 1997
 S3 p. 36-
1 p.
 artikel
3 187 Adenovirus-mediated transfer of urokinase-type plasminogen activator genes to the lungs of mice upregulates plasminogen activator activity Simon, Richard H.
 1997
 S3 p. 53-
1 p.
 artikel
4 97 Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals Eriksson, Per
 1997
 S3 p. 28-
1 p.
 artikel
5 152 A monoclonal antibody to the lbs of apo(a) inhibits binding of apo(a) but not plasminogen to fibrin Anglés-Cano, E.
 1997
 S3 p. 43-
1 p.
 artikel
6 149 Analysis of binding of uPA/inhibitor complexes and Mr 40,000 receptor-associated-protein to very low density lipoprotein receptor Rettenberger, Peter M.
 1997
 S3 p. 42-
1 p.
 artikel
7 98 Analysis of mouse placental development in uPA and uPA:ST3 double null mutants Teesalu, T.
 1997
 S3 p. 28-
1 p.
 artikel
8 146 A novel and simple assay for determination of gelatinase-b (MMP-9) activities in biological fluids Verheijen, Jan
 1997
 S3 p. 41-
1 p.
 artikel
9 3 A novel homeo-domain protein, prep1, forms a regulatory complex with PBX proteins in vivo Berthelsen, Jens
 1997
 S3 p. 2-
1 p.
 artikel
10 30 Antisense oligonucleotides against the urokinase receptor inhibit both urokinase-dependent and growth factors-dependent angiogenesis in vitro Del Rosso, Mario
 1997
 S3 p. 9-
1 p.
 artikel
11 53 A potential mechanism for the trafficking of tissue plasminogen activator (t-PA) to the regulated pathway of secretion: Binding to the major secretory vesicle protein, chromogranin A (CgA) Parmer, R.J.
 1997
 S3 p. 15-
1 p.
 artikel
12 192 A sandwich elisa for components of the plasminogen activation system (PA) which avoids interference with heterophilic antibodies Grebenschikov, N.
 1997
 S3 p. 55-
1 p.
 artikel
13 106 Association of preoperative plasma PAI-1 and CRP levels in patients with colorectal cancer Nielsen, Hans J.
 1997
 S3 p. 30-
1 p.
 artikel
14 54 A tPA/plasmin proteolytic cascade promotes neuronal degeneration in the mammalian hippocampus Tsirka, Stella E.
 1997
 S3 p. 15-
1 p.
 artikel
15 Author index 1997
 S3 p. 57-62
6 p.
 artikel
16 42 Beyond proteolysis: Evidence for a nonproteolytic role for uPAR in cellular migration in vivo Waltz, David A.
 1997
 S3 p. 12-
1 p.
 artikel
17 126 Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2+3 of the urokinase receptor Colman, Robert W.
 1997
 S3 p. 36-
1 p.
 artikel
18 148 Binding of tPA to human vascular smooth muscle cells alters the kinetics of its inactivation by both low molecular weight and macromolecular inhibitors Werner, Finn
 1997
 S3 p. 42-
1 p.
 artikel
19 134 Binding of tPA to human vascular smooth muscle cells: Evidence for a novel, specific receptor Ellis, Vincent
 1997
 S3 p. 38-
1 p.
 artikel
20 131 Binding of uPA·PAI-1 complex to the endocytosis receptors α2MR/LRP and vldlr involves basic residues in the inhibitor Rodenburg, Kees W.
 1997
 S3 p. 37-
1 p.
 artikel
21 150 Breast carcinoma epithelial cells express a very low density lipoprotein receptor variant lacking the olinked glycosylation domain encoded by exon 16, but with normal binding activity for serine proteinase/serpin complexes and Mr 40,000 receptor associated protein Martensen, Pia M.
 1997
 S3 p. 42-
1 p.
 artikel
22 153 Catalytic domain of tissue-type plasminogen activator: The functional role of the surface-located loops and the identification of a hydrophobic exosite that modulates specificity for plasminogen Lamba, D.
 1997
 S3 p. 44-
1 p.
 artikel
23 190 Characterization and targeting of the murine α 2-antiplasmin gene Lijnen, H.R.
 1997
 S3 p. 54-
1 p.
 artikel
24 130 Characterization of a novel endothelial receptor, LR3, that defines a new class of receptors related to the LDL receptor family Hembrough, Todd A.
 1997
 S3 p. 37-
1 p.
 artikel
25 11 Characterization of UEF-4, a DNA binding protein required for transcriptional synergism between two AP-1 sites in the human urokinase enhancer De Cesare, Dario
 1997
 S3 p. 4-
1 p.
 artikel
26 158 Chicken plasminogen activator (chuPA): Autoactivating and serpin resistant: A protease out of control Sipley, John D.
 1997
 S3 p. 45-
1 p.
 artikel
27 193 Clinical, hemostaseological, and moleculargenetic findings in patients with homozygous type I plasminogen deficiency and in their family members Mingers, A.-M.
 1997
 S3 p. 20-
1 p.
 artikel
28 28 Conditioned medium from human trophoblast cells stimulates the expression of tissue type plasminogen activator and urokinase-type plasminogen activator receptor by human umbilical vein endothelial cells Zhang, Jing-Chuan
 1997
 S3 p. 8-
1 p.
 artikel
29 164 Conformational differences between free and complexed forms of uPA and PAI-1, as probed by proteolytic susceptibility Egelund, R.
 1997
 S3 p. 47-
1 p.
 artikel
30 110 Content and localization of protein and mRNA for plasminogen activators in normal, hyperplastic and malignant endometrium Nordengren, J.
 1997
 S3 p. 31-
1 p.
 artikel
31 172 Control of constitutive and regulated secretion of PAI-1, resides in different regions of the PAI-1 molecule Gombau, L.
 1997
 S3 p. 49-
1 p.
 artikel
32 154 Converting tissue type plasminogen activator into a zymogen Tachias, Kathy
 1997
 S3 p. 44-
1 p.
 artikel
33 155 Converting tissue type plasminogen activator into a zymogen: Important role of Lys 156 Tachias, Kathy
 1997
 S3 p. 44-
1 p.
 artikel
34 129 Cooperation between plasmin and membrane-type 1 metalloproteinase (MT1-MMP) in the activation of 72 kDa type IV collagenase (MMP-2) on the cell surface Monea, Sara
 1997
 S3 p. 36-
1 p.
 artikel
35 39 Co-ordinate overexpression of urokinase receptor and αvβ5 vitronectin receptor in breast cancer Carriero, M.V.
 1997
 S3 p. 12-
1 p.
 artikel
36 144 Critical role of the glu-lys plasminogen transition in glu-plasminogen activation on the cell surface Gong, Y.
 1997
 S3 p. 41-
1 p.
 artikel
37 74 Cross-linking of plasminogen activator inhibitor 2 to fibrin Ritchie, Helen
 1997
 S3 p. 22-
1 p.
 artikel
38 7 Cyclic nucleotide regulation of plasminogen activator-inhibitor mRNA stability in rat hepatoma cells: Identification of CIS-acting sequences Heaton, J.H.
 1997
 S3 p. 3-
1 p.
 artikel
39 32 Cytokine-like activities of dep-inactivated uPA Schleuning, Wolf-Dieter
 1997
 S3 p. 9-
1 p.
 artikel
40 8 Destabilising properties of the uuauuuauu element in the 3' UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA Maurer, Fabienne
 1997
 S3 p. 3-
1 p.
 artikel
41 90 Diabetes related increase in plasminogen activator inhibitor-1 expression in monkey retinal capillaries Grant, M.B.
 1997
 S3 p. 26-
1 p.
 artikel
42 23 Differential susceptibility of primary human breast fibroblasts to TGFβ1 coincides with the proneness of these (myo)fibroblasts to produce uPA in response to factor(s) released by human epithelial carcinoma cells in vitro Sieuwets, Anieta M.
 1997
 S3 p. 7-
1 p.
 artikel
43 175 Different mechanisms are involved in the antibody mediated inhibition of the interaction between the urokinase-type plasminogen activator and its receptor List, Kari
 1997
 S3 p. 50-
1 p.
 artikel
44 73 Disruption of vitronectin-mediated binding of plasminogen activator inhibitor-1 to fibrin stimulates tissue-type plasminogen activator induced fibrinolysis Podor, Thomas J.
 1997
 S3 p. 22-
1 p.
 artikel
45 177 Distinguishing the specificities of closely related proteases: Role of P3 in substrate and inhibitor discrimination between tissue type plasminogen activator and urokinase Ke, Song-Hua
 1997
 S3 p. 51-
1 p.
 artikel
46 120 Does the conjunction of plasminogen activators simplity their dosing regimen ? Maksimenko, Alexander V.
 1997
 S3 p. 34-
1 p.
 artikel
47 197 Do plasminogen receptors play a role in breast cancer malignancy? Ranson, Marie
 1997
 S3 p. 56-
1 p.
 artikel
48 162 Early events in PAI-1 inhibition of tPA Shore, Joseph D.
 1997
 S3 p. 46-
1 p.
 artikel
49 112 Effects of estradiol on components of the plasminogen-plasmin system in MDA-MB-231 breast cancer cells stably transfected with the estrogen receptor Levenson, A.S.
 1997
 S3 p. 32-
1 p.
 artikel
50 61 Elevated PAI-1 and tissue factor gene expression in obese mice: A possible mechanism for the increased risk for cardiovascular disease associated with obesity Samad, Fahumiya
 1997
 S3 p. 17-
1 p.
 artikel
51 116 Elisa determination of the complex between urokinase plasminogen activator and its type-1 inhibitor in tumor extracts Pedersen, Anders N.
 1997
 S3 p. 33-
1 p.
 artikel
52 182 Enhanced hybridization by peptide nucleic acids Corey, David R.
 1997
 S3 p. 52-
1 p.
 artikel
53 6 Enhanced stability of uPA mRNA in metastatic breast cancer MDA-MB-231 and melanoma cells, and protein kinase C-downregulated LLC-PK1 cells: Correlation with hnRNP C Nanbu, Rika
 1997
 S3 p. 2-
1 p.
 artikel
54 43 Epidermal growth factor induces u-pa and MMP-9 production and regulates the invasive behavior of epithelial ovarian carcinoma cells Ellerbroek, S.M.
 1997
 S3 p. 13-
1 p.
 artikel
55 189 Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques Ferrier, Cilia
 1997
 S3 p. 54-
1 p.
 artikel
56 188 Establishment of murine monoclonal antibodies against murine urokinase receptor raised in urokinase receptor knock-out mice Rønne, Ebbe
 1997
 S3 p. 54-
1 p.
 artikel
57 26 Expression and regulation of the plasminogen activating system in hepatic stellate cells Fibbi, Gabriella
 1997
 S3 p. 8-
1 p.
 artikel
58 196 Expression of “relaxed” conformation of PAI-2 and LRP in human term gestational tissues Tsatas, D.
 1997
 S3 p. 56-
1 p.
 artikel
59 100 Expression of the urokinase receptor is regulated by hypoxia Graham, Charles H.
 1997
 S3 p. 29-
1 p.
 artikel
60 103 Extracellular matrix degradation and increase in uPA production in mouse cumulus cell-oocyte complexes (COCs) Canipari, R.
 1997
 S3 p. 30-
1 p.
 artikel
61 27 Fatty acids increase plasminogen activator inhibitor-1 expression and secretion in endothelial cells Nilsson, Lennart
 1997
 S3 p. 8-
1 p.
 artikel
62 69 Fibrinogen heterogeneity and fibrin degradaton in homozygous plasminogen deficiency type 1 Dempfle, C.E.
 1997
 S3 p. 20-
1 p.
 artikel
63 167 Fluorescence studies of the dynamics of PAI-1 during complex formation with UPA Fa, Ming
 1997
 S3 p. 48-
1 p.
 artikel
64 45 Formation of capillary tube-like structures in huvecs is regulated in vitro by urokinase-type plasminogen activator via phosphatidylinositol -3 kinase independent signaling pathway Koschelnick, Yu.
 1997
 S3 p. 13-
1 p.
 artikel
65 87 Genetic manipulation of plasminogen activator inhibitor-1 in two distinct cell lines of human fibrosarcoma: Towards understanding the PAI-1 paradox in cancer Carroll, Veronica A.
 1997
 S3 p. 26-
1 p.
 artikel
66 81 Growth and dissemination of lewis lung carcinoma in plasminogen-deficient mice Bugge, Thomas H.
 1997
 S3 p. 24-
1 p.
 artikel
67 71 Healing of corneal epithelial defects in plasminogen-and fibrinogen -deficient mice Kao, W.W.-Y.
 1997
 S3 p. 20-
1 p.
 artikel
68 123 Hepatic clearance and metabolism of TNK-tPA, a long half-life variant of rt-PA De Guzman, Geralyn G.
 1997
 S3 p. 35-
1 p.
 artikel
69 21 Hepatocyte growth factor (HGF) stimulates production of plasminogen activator inhibitor-1 (PAI-1) and vascular endothelial growth factor (VEGF) in human keratinocytes and flk-1 in human endothelial cells in vitro Kaun, C.
 1997
 S3 p. 7-
1 p.
 artikel
70 99 High preoperative blood levels of urokinase plasminogen activator receptor (UPAR) and carcinoembryonic antigen (CEA) defines a group of colorectal cancer patients with poor prognosis Brünner, Nils
 1997
 S3 p. 29-
1 p.
 artikel
71 89 Histochemical studies of matrix degrading proteases in human breast cancer Schnack Nielsen, Boye
 1997
 S3 p. 26-
1 p.
 artikel
72 140 Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis via a neutralization of plasminogen activator inhibitor type 1 activity: Its enhancement by either heparin or vitronectin Urano, T.
 1997
 S3 p. 40-
1 p.
 artikel
73 181 Identification and characterization of small molecule peptidic and non-peptidic urokinase receptor antagonists Rosenberg, Steven
 1997
 S3 p. 52-
1 p.
 artikel
74 34 Identification of a novel membrane protein that interacts specifically with the uPAR-prourokinase complex Behrendt, Niels
 1997
 S3 p. 10-
1 p.
 artikel
75 13 Identification of cofactors involved in the multihormone response of the enhancer located far upstream from the human tissue-type plasminogen activator gene Bulens, F.
 1997
 S3 p. 5-
1 p.
 artikel
76 1 Identification of components of the cell death pathway Dixit, V.M.
 1997
 S3 p. 1-
1 p.
 artikel
77 14 Identification of endothelial nuclear factors which recognise the cre-like element in the human t-PA gene promoter Costa, Magdaline
 1997
 S3 p. 5-
1 p.
 artikel
78 137 Identification of receptors mediating the enhancement of plasminogen activation on U937 cell surfaces Hawley, S.B.
 1997
 S3 p. 39-
1 p.
 artikel
79 68 Impairment of post-lactational involution of the mammary gland in mice deficient for the plasminogen gene Bjørn, S.F.
 1997
 S3 p. 19-
1 p.
 artikel
80 57 Induction of the plasminogen activator system during peripheral nerve regeneration Siconolfi, Lisa B.
 1997
 S3 p. 16-
1 p.
 artikel
81 10 Induction of type-1 plasminogen activator inhibitor (PAI-1) gene expression by thiazolidinediones during adipocyte differentiation Ihara, Hayato
 1997
 S3 p. 4-
1 p.
 artikel
82 125 Inhibition of angiogenesis by blocking vegf action: Mutational analysis of vegf: Receptor binding and epitope mapping of neutralizing antibodies Keyt, Bruce A.
 1997
 S3 p. 35-
1 p.
 artikel
83 85 Inhibition of in vivo tumor growth by murine and human urokinase receptor antagonists Rosenberg, Steven
 1997
 S3 p. 25-
1 p.
 artikel
84 142 Inhibition of lipoprotein(a) binding to fibrinogen, extracellular matrix and cells by apo(a) kiv-10 and plasminogen kringles Xue, S.
 1997
 S3 p. 40-
1 p.
 artikel
85 79 Inhibition of neointima formation in cultured human saphenous vein segments by an adenovirus expressing an urokinase receptor binding plasmin inhibitor Quax, P.H.A.
 1997
 S3 p. 23-
1 p.
 artikel
86 4 Inhibition of the urokinase receptror by antisense oligonucleotides reduces proliferation and binding of nuclear extracts to M67SIE sequence of the c-fos promoter in the human kidney epithelial cell line TCL-598 Ehart, M.
 1997
 S3 p. 2-
1 p.
 artikel
87 184 Inhibition of uPA/uPAR-interaction by cyclic uPA-derived peptides Magdolen, V.
 1997
 S3 p. 53-
1 p.
 artikel
88 2 Integrins and proteases in angiogenesis and disease Cheresh, David A.
 1997
 S3 p. 1-
1 p.
 artikel
89 141 Interaction between the C-X-C chemokine MIP-2α and plasminogen Arza, B.
 1997
 S3 p. 40-
1 p.
 artikel
90 160 Interactions between the plasminogen NTP and kringle 2+3 An, Seong Soo A.
 1997
 S3 p. 46-
1 p.
 artikel
91 180 Inventory of “atherosclerotic genes” induced or repressed in endothelial cells and smooth muscle cells by differential display RT-PCR Horrevoets, Anton J.G.
 1997
 S3 p. 51-
1 p.
 artikel
92 92 In vitro angiogenesis: Effect of hypoxia on u-PA and u-PA receptor expression Kroon, M.E.
 1997
 S3 p. 27-
1 p.
 artikel
93 117 Isolation and characterization of gene expression in nonmetastasizing versus metastasizing human breast cancer cells Engelholm, L.
 1997
 S3 p. 33-
1 p.
 artikel
94 138 Isolation of an angiostatin receptor from the membranes of human umbilical vein endothelial cells Moser, Tammy L.
 1997
 S3 p. 39-
1 p.
 artikel
95 55 Kainic acid-induced seizures elevate PAI-1 mRNA in brain and cardiac parenchyme and blood vessels Bhuvarahamurthy, Venugopal
 1997
 S3 p. 16-
1 p.
 artikel
96 64 Leucocyte and plasma PAs and PAIs in patients with cardiovascular collapse in sepsis Dummer, S.
 1997
 S3 p. 18-
1 p.
 artikel
97 165 Ligand binding determinants within the receptor for urokinase-type plasminogen activator as delineated by photolabelling and site-directed mutagenesis Ploug, Michael
 1997
 S3 p. 47-
1 p.
 artikel
98 72 Ligneous conjunctivitis in plasminogen-deficient mice Drew, A.F.
 1997
 S3 p. 21-
1 p.
 artikel
99 52 Localized expression of tissue plasminogen activator excludes fibrin formation in pulmonary arterioles Levin, Eugene G.
 1997
 S3 p. 15-
1 p.
 artikel
100 195 Lysine-dependant Glu-Plasminogen binding to α-enolase induces conformational changes resulting in higher affinity interactions Andronicos, Nicholas
 1997
 S3 p. 56-
1 p.
 artikel
101 156 Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single chain human tPA and vampire bat plasminogen activator Renatus, Martin
 1997
 S3 p. 44-
1 p.
 artikel
102 143 Mechanism of vimentin-dependent inhibition of fibrinolysis at sites of tissue injury and platelet deposition Foulon, Denise M.
 1997
 S3 p. 40-
1 p.
 artikel
103 171 Mechanisms of neutralization of the inhibitory activity of PAI-1 by monoclonal antibodies directed against the β-strand 1A/α-helix F region Schousboe, S.L.
 1997
 S3 p. 49-
1 p.
 artikel
104 136 Modulation of plasminogen receptor expression on leukocytes Herren, Thomas
 1997
 S3 p. 38-
1 p.
 artikel
105 186 Modulation of vascular cell plasminogen activation by gene transfer In Vitro De Young, Mary Beth
 1997
 S3 p. 53-
1 p.
 artikel
106 15 Molecular cloning and functional studies of P113: A transcription factor that regulates the expression of acetyl-coa carboxylase (ACC) and PAI-1 Zhang, Qi
 1997
 S3 p. 5-
1 p.
 artikel
107 170 Molecular cloning, expression, crystallization and mutation of staphylokinase Hou-Yan, Song
 1997
 S3 p. 49-
1 p.
 artikel
108 173 Molecular structure of staphylokinase involved in the expression of its plasminogen activator activity Ueshima, S.
 1997
 S3 p. 49-
1 p.
 artikel
109 59 Mouse models for the study of pai function in tissue injury and repair Ginsburg, David
 1997
 S3 p. 17-
1 p.
 artikel
110 169 Mutational analysis of binding determinants in the human receptor for urokinase-type plasminogen activator Gårdsvoll, Henrik
 1997
 S3 p. 48-
1 p.
 artikel
111 56 Neurosepin, a specific brain-associated inhibitor of tissue plasminogen activator (tPA) Sandkvist, Maria
 1997
 S3 p. 16-
1 p.
 artikel
112 49 Non-proteolytic role of urokinase-type plasminogen activator system in human breast cancer cells migration Chazaud, Bénédicte
 1997
 S3 p. 14-
1 p.
 artikel
113 93 Novel extracellular matrix-associated human plasmin inhibitors and their role in the degradation and invasion of matrix by tumor cells Rao, C.N.
 1997
 S3 p. 27-
1 p.
 artikel
114 133 On the role of plasminogen activator inhibitor type-2(PAI-2) in cell survival Antalis, Toni M.
 1997
 S3 p. 38-
1 p.
 artikel
115 47 PAI-1: An adhesion molecule used incell migration Chazaud, Bénédicte
 1997
 S3 p. 14-
1 p.
 artikel
116 121 PAI-1 as a new target for anthnvasive and antimetastatic therapy Frandsen, T.L.
 1997
 S3 p. 34-
1 p.
 artikel
117 122 PAI-1 in various blood transfusion preparations Hammer, Janne H.
 1997
 S3 p. 34-
1 p.
 artikel
118 35 Pai-1 regulates u-PAR- and integrin-mediated adhesion of cells to vitronectin Deng, G.
 1997
 S3 p. 11-
1 p.
 artikel
119 124 Pharmacokinetics and dynamics of longer half-life and PAI-1 resistant tissue plasminogen activator mutants: Slow clearing molecules are not rapidly inhibited Keyt, Bruce A.
 1997
 S3 p. 35-
1 p.
 artikel
120 67 Physiological consequenses of plasminogen deficiency on fertility and ovulation efficiency Ny, A.
 1997
 S3 p. 19-
1 p.
 artikel
121 63 Plasmin activation of insulin-like growth factors in the bone pericellular environment Campbell, Phil G.
 1997
 S3 p. 18-
1 p.
 artikel
122 95 Plasminogen activation in human leukemia Mustjoki, S.
 1997
 S3 p. 28-
1 p.
 artikel
123 115 Plasminogen activation in melanoma: An immuno-histochemical study Ferrier, Cilia
 1997
 S3 p. 33-
1 p.
 artikel
124 50 Plasminogen activation system in tumor apoptosis Kwaan, Hau C.
 1997
 S3 p. 14-
1 p.
 artikel
125 132 Plasminogen activator inhibitor-1 (PAI-1) a molecular switch that contains a cryptic high affinity binding site for the low density lipoprotein receptor related protein (LRP) Stefansson, S.
 1997
 S3 p. 37-
1 p.
 artikel
126 36 Plasminogen activator inhibitor type-1 inhibits integrin- and vitronectin-dependent cell migration Kjøller, L.
 1997
 S3 p. 11-
1 p.
 artikel
127 118 Poor differentiation in malignant serous ovarian tumors is accompanied by stromal expression of the urokinase plasminogen activator Borgfeldt, Christer
 1997
 S3 p. 33-
1 p.
 artikel
128 101 Possible involvement of tPA in the demyelinating disease of multiple sclerosis: Cerebrospinal fluid and plasma studies Akenami, F.O.T.
 1997
 S3 p. 29-
1 p.
 artikel
129 38 Post-translational plasmin proteolysis of laminin-5 regulates hemidesmosome assembly and cell motility Stack, M.S.
 1997
 S3 p. 11-
1 p.
 artikel
130 145 Procarboxypeptidase u is expressed in human liver Vanhoof, Greet
 1997
 S3 p. 41-
1 p.
 artikel
131 185 Rapid and efficient site-directed mutagenesis by single-tube ‘megaprimer’ PCR method Ke, Song-Hua
 1997
 S3 p. 53-
1 p.
 artikel
132 78 Receptor-independent role of urokinase-type plasminogen activator during vascular wound healing in mice Carmeliet, P.
 1997
 S3 p. 23-
1 p.
 artikel
133 82 Reduced breast cancer metastasis in plasminogen-deficient mice Bugge, Thomas H.
 1997
 S3 p. 24-
1 p.
 artikel
134 76 Reduced transplant arteriosclerosis in plasminogen deficient mice Moons, L.
 1997
 S3 p. 22-
1 p.
 artikel
135 86 Reduction of tumor cell migration and metastasis by plasminogen activator inhibitor gene transfer Praus, M.
 1997
 S3 p. 25-
1 p.
 artikel
136 22 Regulation of both PAI-1 and the uPAR by HGF and TGF-β in primary cultures of rat hepatocytes Wang, X.
 1997
 S3 p. 7-
1 p.
 artikel
137 16 Regulation of hepatic type-1 plasminogen activator inhibitor (PAI-1) by mediators of the acute phase response Gelehrter, T.D.
 1997
 S3 p. 5-
1 p.
 artikel
138 66 Regulation of plasminogen activators and matrix metalloproteinases during development and regression of the corpus luteum in the mouse Liu, Kui
 1997
 S3 p. 19-
1 p.
 artikel
139 105 Regulation of the single chain urokinase/urokinase receptor complex by fibrin and plasminogen Al Roof Higazi, Abd
 1997
 S3 p. 30-
1 p.
 artikel
140 108 Relationship between PAI-1 promoter polymorphism and PAI-1 circulating levels in postmenopausal women with coronary artery disease (CAD) Grancha, S.
 1997
 S3 p. 31-
1 p.
 artikel
141 84 Role of matrix degrading proteinases in wound healing and skin cancer Lund, Leif R.
 1997
 S3 p. 25-
1 p.
 artikel
142 75 Role of plasminogen and fibrinogen in atherosclerosis Xiao, Qing
 1997
 S3 p. 22-
1 p.
 artikel
143 18 Role of Sp1 and Sp3 in basal and hormone-induced transcriptional activity of the human t-PA gene promoter Merchiers, P.
 1997
 S3 p. 6-
1 p.
 artikel
144 94 Role of thrombomodulin in the inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu Braat, Ellen
 1997
 S3 p. 27-
1 p.
 artikel
145 96 Role of urokinase (uPA) and its receptor (uPAR) in breast cancer growth, invasion and metastasis: Potential therapeutic strategies Hongmei Xing, Rosie
 1997
 S3 p. 28-
1 p.
 artikel
146 88 Secretion of plasminogen activator inhibitor 2 by human monocytes Ritchie, Helen
 1997
 S3 p. 26-
1 p.
 artikel
147 179 Serial analysis of gene expression (sage) to study the endothelial cell response to an atherogenic stimulus Jan van Zonneveld, Anton
 1997
 S3 p. 51-
1 p.
 artikel
148 119 Soluble human urokinase receptor in plasma of nude mice during the growth of human breast cancer xenografts Holst-Hansen, Claus
 1997
 S3 p. 34-
1 p.
 artikel
149 113 Soluble receptors for u-PA in blood and peritoneal-ascitic fluid are increased in patients with malignant ovarian tumors Wahlberg, K.
 1997
 S3 p. 32-
1 p.
 artikel
150 62 Spontaneous thrombosis in mice carrying the APC resistance mutation (FV leiden) introduced by gene targeting Cui, J.
 1997
 S3 p. 18-
1 p.
 artikel
151 51 Storage and release of tissue-type plasminogen activator from a unique tubulovesicular network in activated human endothelial cells Podor, Thomas J.
 1997
 S3 p. 15-
1 p.
 artikel
152 166 β-Strand 5A residues glutamine 321, glutamine 324 and lysine 325 are important for inhibitory function in PAI-1 Kirkegaard, Tove
 1997
 S3 p. 48-
1 p.
 artikel
153 83 Stromal cell involvement and functional overlap in extracellular proteolysis in cancer invasion and non-neoplastic tissue remodeling Danø, Keld
 1997
 S3 p. 24-
1 p.
 artikel
154 147 Stromelysin-3 is induced during apoptosis in ovarian follicles undergoing atresia Hägglund, A.-C.
 1997
 S3 p. 41-
1 p.
 artikel
155 159 Structure and ligand binding properties of the kringle 5 domain of human plasminogen Castellino, F.J.
 1997
 S3 p. 45-
1 p.
 artikel
156 176 Structure-function consequences of mutations of aromatic residues of the kringle 2 domain of tissue-type plasminogen activator Chang, Y.
 1997
 S3 p. 50-
1 p.
 artikel
157 168 Structure function studies on the urokinase receptor: Urokinase system. Murine-human hybrid proteins define critical regions for species specificity Stratton-Thomas, Jennifer R.
 1997
 S3 p. 48-
1 p.
 artikel
158 194 Subcellular distribution of urokinase-type plasminogen activator and uPA-receptor in neutrophils determined by immunogold labeling and electron microscopy Lindhardt Pedersen, Trine
 1997
 S3 p. 56-
1 p.
 artikel
159 70 Successful therapy with Lys-Plasminogen in homozygous type 1 plasminogen deficiency Schott, D.
 1997
 S3 p. 20-
1 p.
 artikel
160 191 Targeted disruption of mouse protein C inhibitor gene Ulhrin, P.
 1997
 S3 p. 54-
1 p.
 artikel
161 178 Targeting proteolysis to non-physiological protein substrates Corey, David R.
 1997
 S3 p. 51-
1 p.
 artikel
162 157 The “activation domain”: A highly cooperative entity within the catalytic domain of serine proteinases Bode, Wolfram
 1997
 S3 p. 45-
1 p.
 artikel
163 17 The enhancer of the human uPA gene is accessible to trancription factors in both uninduced and TPA-induced HepG2 cells Ibañez-Tallon, I.
 1997
 S3 p. 6-
1 p.
 artikel
164 107 The immunohistological localization of the different components of the plasminogen activation system in breast cancer Christensen, Lise
 1997
 S3 p. 31-
1 p.
 artikel
165 161 The inhibitory mechanism of serpins revealed by structural determination of serpin-protease complexes Wilczynska, Malgorzata
 1997
 S3 p. 46-
1 p.
 artikel
166 41 The intact urokinase receptor is required for high affinity vitronectin binding: Receptor cleavage prevents ligand interaction Høyer-Hansen, Gunilla
 1997
 S3 p. 12-
1 p.
 artikel
167 60 The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis Yamamoto, Koji
 1997
 S3 p. 17-
1 p.
 artikel
168 139 The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin Gately, Stephen
 1997
 S3 p. 39-
1 p.
 artikel
169 5 The multi-hormone responsive enhancer located far upstream from the human tissue-type plasminogen activator gene confers induction by vitamin D Bulens, F.
 1997
 S3 p. 2-
1 p.
 artikel
170 58 The plaminogen activation system in bone and cartilage degradation in vitro and in vivo Verheijen, Jan
 1997
 S3 p. 17-
1 p.
 artikel
171 65 The plasminogen system in pulmonary fibrosis Swaisgood, Carmen M.
 1997
 S3 p. 19-
1 p.
 artikel
172 9 The proximal region of the human uPA gene promoter is involved in the response to DNA damage Kopf, Eliezer
 1997
 S3 p. 4-
1 p.
 artikel
173 44 The receptor for urokinase type plasminogen activator is deposited on the substratum by both normal and tumorderived human cells in culture: Studies by fluorescence and photoelectron microscopy Hedberg, Karen K.
 1997
 S3 p. 13-
1 p.
 artikel
174 20 The role of downstream sequences in the regulation of transcriptional activity of the human urokinase receptor promoter Grebe, A.
 1997
 S3 p. 6-
1 p.
 artikel
175 80 The role of uPAR deficiency in induction of cancer dormancy Yu, W.
 1997
 S3 p. 24-
1 p.
 artikel
176 33 The urokinase-sensitive region of the urokinase receptor is responsible for its potent chemotactic activity Blasi, F.
 1997
 S3 p. 10-
1 p.
 artikel
177 40 The urokinase-type plasminogen activator promotes proliferation of human ovarian carcinoma cells Fischer, Kerstin
 1997
 S3 p. 12-
1 p.
 artikel
178 111 Thrombolytic composition consisting of tissue-type plasminogen activator and urokinase-fibrinogen covalent conjugate : Results of biomedical investigation Maksimenko, A.V.
 1997
 S3 p. 32-
1 p.
 artikel
179 135 Tissue plasminogen activator binding to the tail domain of its endothelial cell receptor, annexin II: Direct modulation by homocysteine Hajjar, K.A.
 1997
 S3 p. 38-
1 p.
 artikel
180 183 TNK-tissue plasminogen activator compared with front-loaded TPA in acute myocardial infarction: Clinical update Keyt, Bruce A.
 1997
 S3 p. 52-
1 p.
 artikel
181 109 tPA-mediated plasminogen activation in human melanocyte-melanoma system Bizik, J.
 1997
 S3 p. 31-
1 p.
 artikel
182 12 Transcriptional regulation of the human urokinase-type plasminogen activator receptor gene Parry, Graham C.N.
 1997
 S3 p. 4-
1 p.
 artikel
183 24 Transcriptional regulation of urokinase (uPA) gene expression in hormone dependent malignancies Xing, Rosie
 1997
 S3 p. 7-
1 p.
 artikel
184 151 Unexpected cooperation between uPA and TIMP-2 during myogenic differentiation in vitro Planchenault, Thierry
 1997
 S3 p. 42-
1 p.
 artikel
185 48 uPA induces adhesion of tumor cells in vitro Kwaan, Hau C.
 1997
 S3 p. 14-
1 p.
 artikel
186 31 uPA/uPAR stimulates tumor cell migration by enhancing integrin-mediated signal transduction Yebra, Mayra
 1997
 S3 p. 9-
1 p.
 artikel
187 25 Upstream promoter elements required for basal and monocyte specific transcription of the human urokinase receptor gene Soravia, E.
 1997
 S3 p. 8-
1 p.
 artikel
188 77 Urokinase-generated plasmin induces athero-sclerotic aneurysm formation via activation of matrix metalloproteinases Carmeliet, P.
 1997
 S3 p. 23-
1 p.
 artikel
189 19 Urokinase mediated induction of an interferon (IFN) responsive gene promoter may utilise IFN α-stimulated gene response elements (ISRE) Dear, Anthony E.
 1997
 S3 p. 6-
1 p.
 artikel
190 29 Urokinase plasminogen activator promotes keratinocyte proliferation in vivo Collen, D.
 1997
 S3 p. 9-
1 p.
 artikel
191 102 Urokinase plasminogen activator receptor in plasma is an independent prognostic variable in patients with colorectal cancer Stephens, Ross W.
 1997
 S3 p. 29-
1 p.
 artikel
192 114 Urokinase plasminogen activator (u-PA) has paracrine functions in endometrial regeneration Casslén, Bertil
 1997
 S3 p. 32-
1 p.
 artikel
193 46 Urokinase plasminogen activator (U-PA), released from endometrial stromal cells, stimulated with tgfβ1, can affect endometrial regeneration and angiogenesis Tove, Sandberg
 1997
 S3 p. 13-
1 p.
 artikel
194 104 Urokinase receptor in serum of ovarian cancer patients Sier, Kees
 1997
 S3 p. 30-
1 p.
 artikel
195 37 Urokinase receptor mediated vitronectin adhesion of transfected myeloid 32D cells Sidenius, N.
 1997
 S3 p. 11-
1 p.
 artikel
196 91 Urokinase (uPA) activity, a mediator of the invasive phenotype conferred by CSF-1 in epithelial ovarian cancer Chambers, S.K.
 1997
 S3 p. 27-
1 p.
 artikel
197 163 Vitronectin induces conformational changes of the hinge of the reactive centre loop and of β-strand 5A and affects inhibitor-to-substrate transition of PAI-1 Jensen, S.
 1997
 S3 p. 46-
1 p.
 artikel
                             197 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland